Following Dr Giedrius Gasiunas’ presentation on the compact Cas12l CRISPR-Cas editor at the ASGCT Annual Meeting in Boston, a new GEN article highlights Caszyme’s development work on this promising genome editing platform.

Thanks to its compact size and C-rich PAM recognition, Cas12l opens exciting opportunities: expanding the CRISPR toolbox and positioning itself as a compelling alternative to Cas9.

Read the full GEN article here.